Arto Leminen

Box, 00029, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Treatment of gynecological malignancies: long-term follow-up of health-related quality of life and healthcare costs.

Treatment of gynecological malignancies: long-term follow-up of health-related quality of life and healthcare costs.

Journal: Journal of comparative effectiveness research

Published: March 30, 2019

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.

Journal: Gynecologic oncology

Published: September 24, 2018

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Journal: British journal of cancer

Published: August 08, 2017

Prediction of Site-Specific Tumor Relapses in Patients With Stage I-II Endometrioid Endometrial Cancer.

Prediction of Site-Specific Tumor Relapses in Patients With Stage I-II Endometrioid Endometrial Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 13, 2017

Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort.

Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort.

Journal: Gynecologic oncology

Published: November 15, 2016

Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.

Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.

Journal: Gynecologic oncology

Published: October 26, 2016

Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors.

Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors.

Journal: Gynecologic oncology

Published: August 06, 2016

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

Journal: International journal of epidemiology

Published: June 24, 2016

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

Journal: Nature genetics

Published: June 04, 2016

Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.

Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.

Journal: Oncotarget

Published: April 08, 2016

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.

Journal: International journal of epidemiology

Published: April 07, 2016

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

Journal: Journal of genetics and genome research

Published: January 26, 2016

Showing 1-12 of 53

Last Updated: 09/26/2026